A new wave of cancer treatments is looking promising for the future of oncologic care. The ovarian cancer drug RC88, which is made by the Chinese biopharmaceutical company RemeGen, received FDA ...
Researchers credit widespread HPV vaccination for a historic milestone that could reshape the future of cancer prevention.
Presented at ESTRO 2025 in Vienna, Austria, a 10-year study involving over 4,000 UK patients confirms that a one-week course of post-surgery radiotherapy is just as safe and effective as the ...
A second dendritic cell vaccine has received fast track designation from the Food and Drug Administration. The Food and Drug Administration (FDA) has granted a fast track designation to a dendritic ...
The Fast Track designation is designed to help promising medicines for serious diseases reach patients faster by allowing more frequent contact with regulators and potentially quicker review.
A newly identified colon cancer gene may drive the disease by making the environment in the vicinity of tumors more hospitable to them, researchers say. The gene, which appears to speed tumor growth ...
A research team in the Department of Pharmacology and Pharmacy at the LKS Faculty of Medicine of the University of Hong Kong (HKUMed), has conducted a pioneering study that found an association ...
Although liver disease is often mild in its early stages, some people will progress to more serious liver damage and a higher ...
KIRKLAND, QC, May 26, 2026 /CNW/ - Pfizer Canada announces that BRAFTOVI® (encorafenib) will be funded under Ontario's Funding Accelerated for Specific Treatments (FAST) program. Following positive ...
See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. An oncology student has shocked TikTok with a viral video that offers a ...
The landscape of cancer prevention has been dramatically illuminated by groundbreaking research from the American Cancer Society, revealing that over 40% of cancer cases in adults over 30 are linked ...
New research in the January 2023 issue of Journal of the National Comprehensive Cancer Network finds that immunotherapy from immune checkpoint (PD-1) inhibitors prior to surgery was strikingly ...